Most people who travel abroad come home with nothing worse than jet lag and a camera roll. But a meaningful minority return carrying an infection that has not yet declared itself. This article establishes what genuinely warrants concern in the days, weeks, and even years after international travel — which symptoms are urgent, which parasites are notorious for hiding, and why the timing of illness relative to a trip is itself a diagnostic clue that patients and physicians should take seriously.
Why the Calendar Still Matters
The single most useful piece of information a returning traveler can give a doctor is not just where they went, but when symptoms started relative to the trip. Parasitic infections do not all behave like a common cold, arriving quickly and resolving on their own timeline. Malaria typically incubates seven to thirty days, though it can surface months later depending on the species involved. Giardia usually causes symptoms one to three weeks after exposure. Schistosomiasis often produces its first acute symptoms two to eight weeks after freshwater contact, a delayed pattern that catches many travelers off guard because the exposure itself felt trivial — a swim, a wade, a splash. Strongyloides and Chagas disease are in a category of their own: both can remain silent for years, even decades, only to cause serious illness when something else in the body changes, such as the immune suppression that comes with cancer treatment or organ transplantation.
This is why any clinician taking a travel history should ask not just "where did you go" but "what did you eat, drink, wade into, or get bitten by, and how long ago." Stewardship of one's own health means keeping that information on hand and volunteering it, even to a doctor who does not think to ask.
Fever After Travel: Rule Out Malaria First
Of every syndrome a returned traveler might present with, fever is the one that deserves the least patience. The GeoSentinel Surveillance Network, a collaboration founded by the CDC and the International Society of Travel Medicine that has tracked illness in tens of thousands of ill returned travelers since the 1990s, published a landmark analysis in the New England Journal of Medicine in 2006. Among travelers presenting with a systemic febrile illness, malaria was identified as the single most common specific cause overall, and it accounted for a substantially larger share of fevers among those returning from sub-Saharan Africa than from any other region. Plasmodium falciparum, the species responsible for the most severe disease, can progress from mild fever to organ failure within days.
Malaria is not, strictly speaking, an "exotic" diagnosis to rule out last — it is the one to rule out first in anyone with fever after travel to an endemic region, regardless of how mild the symptoms seem or whether preventive medication was taken correctly. A blood smear or rapid antigen test can confirm or exclude it within hours. Treatment today generally relies on artemisinin-based combination therapies, a direct descendant of the compound isolated from the sweet wormwood plant, Artemisia annua, by the Chinese scientist Tu Youyou — work grounded in centuries-old herbal medical texts and honored with a share of the 2015 Nobel Prize in Physiology or Medicine. It is a fitting reminder that some of medicine's most important tools were already present in the created world, waiting to be understood rather than invented.
Persistent Gut Trouble: Giardia and Amoebae
Diarrhea that starts during travel and simply does not resolve after returning home is the classic presentation of giardiasis, caused by the protozoan parasite Giardia duodenalis. It is acquired through contaminated water or food and is common enough among travelers to South and Central Asia, Russia, and parts of Africa that it is often the default suspicion when gastrointestinal symptoms drag past two weeks. Giardia rarely causes fever or blood in the stool; instead it produces bloating, foul-smelling stool, and fatigue that can persist for months if untreated. Stool antigen testing or PCR confirms the diagnosis, and treatment with metronidazole or tinidazole is generally effective, though neither drug is approved for use in early pregnancy without a physician's careful weighing of risks and benefits.
A second organism worth distinguishing is Entamoeba histolytica, the cause of amebiasis, which unlike Giardia can cause bloody diarrhea and, in a small proportion of cases, migrate to the liver and form an abscess — sometimes presenting weeks after the intestinal symptoms have faded and without any diarrhea at all. Right upper quadrant pain and fever in a traveler with a Latin American, South Asian, or African itinerary should prompt testing for this specifically, since the treatment differs from that of ordinary bacterial gastroenteritis.
Skin Signs and Water Exposure: Larva Migrans and Schistosomiasis
Skin findings after travel are often dismissed as insect bites, and sometimes that is exactly what they are. But two patterns deserve closer attention. The first is cutaneous larva migrans: an intensely itchy, red, winding track that advances slowly across the skin, most often on the feet or buttocks after walking barefoot on tropical beaches in the Caribbean, Central America, or Southeast Asia. It is caused by hookworm larvae, usually Ancylostoma braziliense, that normally infect dogs and cats but wander harmlessly, if maddeningly, under human skin since they cannot complete their life cycle there. It is treated effectively with ivermectin or albendazole.
Ivermectin is worth pausing on. It was developed from avermectin, a compound isolated from a soil bacterium, Streptomyces avermitilis, by the Japanese microbiologist Satoshi Ōmura, and further developed by William Campbell — work that earned both scientists a share of the 2015 Nobel Prize. It transformed the treatment of several parasitic diseases worldwide. It is not, however, approved for treating COVID-19 or other viral illnesses, and readers should understand that its established, evidence-backed uses are for specific parasitic infections such as this one, strongyloidiasis, and onchocerciasis.
The second pattern is Katayama syndrome, the acute phase of schistosomiasis, which follows freshwater swimming or wading in rivers and lakes across sub-Saharan Africa, parts of South America, and Southeast Asia. Fever, hives, muscle aches, and cough appear two to eight weeks after exposure to water containing the larval stage of Schistosoma flukes, which penetrate intact skin. Outbreaks among European and North American travelers swimming in Lake Malawi have been documented repeatedly in travel medicine journals since the 1990s, often affecting entire tour groups who shared the same lake exposure. Diagnosis relies on serology, since eggs may not yet appear in stool or urine during this acute phase, and treatment with praziquantel is most effective once the parasite has matured enough for the drug to act on it — sometimes requiring a repeat dose weeks later.
The Eosinophilia Clue: Strongyloides and the Danger of Silence
Eosinophils are a type of white blood cell that rises in number specifically in response to parasitic and allergic disease, and an elevated eosinophil count on a routine blood test, found incidentally or ordered because of vague symptoms, is one of the most useful clues in travel medicine. Any returned traveler with unexplained eosinophilia should be evaluated for Strongyloides stercoralis, a soil-transmitted roundworm found throughout the tropics and subtropics, including parts of the rural southeastern United States.
Strongyloides is unusual among human parasites because it can complete an entire life cycle inside the human gut without ever leaving the body, a process called autoinfection. This allows it to persist, often silently, for decades. Case reports well documented in the medical literature describe veterans and immigrants developing severe, sometimes fatal hyperinfection syndrome forty or fifty years after their last exposure, typically triggered by corticosteroid treatment or other immune suppression given for an unrelated condition. This is precisely why physicians are taught to ask about remote travel history before starting steroids in anyone who has ever lived in or visited an endemic area, and why a single stool test is not considered sufficient to exclude it — serologic testing is more sensitive and is recommended for anyone with a suggestive travel history and unexplained eosinophilia.
Preparedness: What Responsible Travelers Do
Much of this risk is manageable through ordinary preparation rather than anxiety. Before travel to malaria-endemic regions, appropriate chemoprophylaxis, discussed with a physician or travel clinic well in advance, remains the best-studied protection. Avoiding freshwater swimming in schistosomiasis-endemic regions, wearing footwear on tropical beaches, and being cautious with untreated water and street food all reduce risk substantially. After returning, it is reasonable — and increasingly recommended by travel medicine specialists — for anyone who spent extended time in the tropics, particularly with rural exposure, freshwater contact, or unexplained gastrointestinal symptoms, to request screening bloodwork including a complete blood count and, where appropriate, targeted serologies, even if they feel entirely well. This is simply informed stewardship of one's own health and, where children were part of the trip, of theirs.
Patients have every right to ask their physician directly why a test is or is not being ordered, and to seek a second opinion or a travel medicine referral if answers feel incomplete. Good medicine is a partnership, not a one-way instruction, and a traveler who has walked through a Zambian village or waded in a Southeast Asian river knows details about that exposure that no textbook can supply.
Key takeaway: any fever, persistent gut trouble, unusual skin finding, or unexplained eosinophilia following international travel deserves prompt medical evaluation with a full travel history in hand, since several parasitic infections are treatable if caught early but dangerous if allowed to persist unseen.